Literature DB >> 15370404

Treatment and follow-up of persistent granulomatous cheilitis with intralesional steroid and metronidazole.

B Coskun1, Y Saral, D Cicek, N Akpolat.   

Abstract

Granulomatous cheilitis (GC) is a chronic edema which frequently affects the upper lip due to granulomatous inflammation. Its etiology is currently unknown. This rare disease is generally accompanied by Melkersson-Rosenthal syndrome (MRS), characterized by scrotal tongue, orofacial edema and facial paralysis. However, it is also known to develop only with orofacial edema. Granulomatous cheilitis is a difficult disease to treat because of recurrences. There are contradictory reports about the results of treatment without surgical intervention and the rates of recurrence. Our case was a 57-year-old female patient who was characterized by orofacial edema only. The edema and erythema had persisted for 1 year before admission. In the present case, application of intralesional corticosteroid treatment as a total of three injections over 3 consecutive months (one injection per month) and the accompanying metronidazole treatment brought about successful results. No recurrence was observed in the follow-up.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370404     DOI: 10.1080/09546630410015538

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  3 in total

1.  Granulomatous cheilitis: successful treatment of two recalcitrant cases with combination drug therapy.

Authors:  Ambika Gupta; Harneet Singh
Journal:  Case Rep Dermatol Med       Date:  2014-10-15

2.  Cheilitis granulomatosa.

Authors:  Sukumaran Pradeep Nair
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

3.  Long-term effectiveness of intralesional triamcinolone acetonide therapy in orofacial granulomatosis: an observational cohort study.

Authors:  S Fedele; P P L Fung; N Bamashmous; A Petrie; S Porter
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.